AmDen Pharmaceuticals Denmark ApS — Credit Rating and Financial Key Figures

AmDen Pharmaceuticals Denmark ApS (CVR number: 42045403) is a company from STEVNS. The company recorded a gross profit of -7.8 kDKK in 2024. The operating profit was -7.8 kDKK, while net earnings were -7.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was -21.4 %, which can be considered poor and Return on Equity (ROE) was -28.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 63.6 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. AmDen Pharmaceuticals Denmark ApS's liquidity measured by quick ratio was 2.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.